Reduced Circulating Lipoprotein A Concentration C5937285
A blood test finding showing abnormally low lipoprotein(a) levels. This is often a benign laboratory finding. Clinical significance depends on the context and other health factors.
Key facts at a glance
- ICD-10
- E88.9
- ICD-11
- 5A00.0
- Body system
- metabolic
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Fatigue or weight changes
(metabolic)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Generalized fatigue
(metabolic)Mild abdominal discomfort
(metabolic)Decreased appetite
(metabolic)Weight loss
(metabolic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Behavioral and nutritional therapy
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Cardiovascular exercise program
Regular aerobic exercise to support overall cardiovascular health and potentially influence lipid metabolism, though Lp(a) reduction from lifestyle alone is typically modest.
Mediterranean-style diet
Plant-focused dietary pattern rich in olive oil, fish, nuts, fruits, and vegetables that supports cardiovascular health and may provide modest benefits to lipid profiles.
Additional treatment options
Cardiovascular risk stratification
Comprehensive cardiovascular assessment including lipid panel, blood pressure, and family history evaluation to determine overall ASCVD risk and need for intensified therapy.
monitoringNiacin supplementation consideration
Niacin therapy may be considered under physician supervision for additional lipid modification, though its specific effect on Lp(a) is limited and must be weighed against side effects.
dietarySmoking cessation and alcohol reduction
Elimination of tobacco use and moderation of alcohol consumption to reduce cardiovascular risk, as smoking compounds the thrombotic risk associated with elevated Lp(a).
lifestyleMedication Comparisons
Compare medications used to treat Reduced Circulating Lipoprotein A Concentration C5937285. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy